Updated software improves slicing for large-format 3D printing
Technology developed at ORNL to monitor plant productivity and health at wide scales has been licensed to Logan, Utah-based instrumentation firm Campbell Scientific Inc.
Tackling the climate crisis and achieving an equitable clean energy future are among the biggest challenges of our time.
The rapid pace of global climate change has added urgency to developing technologies that reduce the carbon footprint of transportation technologies, especially in sectors that are difficult to electrify.
Surrounded by the mountains of landlocked Tennessee, Oak Ridge National Laboratory’s Teri O’Meara is focused on understanding the future of the vitally important ecosystems lining the nation’s coasts.
ORNL, TVA and TNECD were recognized by the Federal Laboratory Consortium for their impactful partnership that resulted in a record $2.3 billion investment by Ultium Cells, a General Motors and LG Energy Solution joint venture, to build a battery cell manufacturing plant in Spring Hill, Tennessee.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory and the Georgia Institute of Technology is using supercomputing and revolutionary deep learning tools to predict the structures and roles of thousands of proteins with unknown functions.
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
Improved data, models and analyses from ORNL scientists and many other researchers in the latest global climate assessment report provide new levels of certainty about what the future holds for the planet
The Department of Energy’s Office of Science has selected five Oak Ridge National Laboratory scientists for Early Career Research Program awards.
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.